Background: Sorafenib-induced dermatologic toxicity is common and consists primarily of dry skin, maculopapular rash, hand-foot skin reaction, and alopecia. Cutaneous squamous cell carcinoma (SCC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback